{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:29:52Z","timestamp":1787142592487,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcrc.2025.155254","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T22:09:37Z","timestamp":1758060577000},"page":"155254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Continuous infusion of Beta-Lactams in the critically ill: Considerations for global implementation"],"prefix":"10.1016","volume":"91","author":[{"given":"Kerina J.","family":"Denny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Best-Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Dulhunty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andries G.S.","family":"Gous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia R.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha Pai","family":"Mangalore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorrilyn","family":"Rajbhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Scribante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcrc.2025.155254_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10219","key":"10.1016\/j.jcrc.2025.155254_bb0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2025.155254_bb0015","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.2147\/IDR.S390947","article-title":"Understanding post-sepsis syndrome: how can clinicians help?","volume":"16","author":"van der Slikke","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155254_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"Beta-Lactams and beta-Lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155254_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.18923","article-title":"Trends in empiric broad-spectrum antibiotic use for suspected community-onset Sepsis in US hospitals","volume":"7","author":"Rhee","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155254_bb0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.2016.1164690","article-title":"The use and risks of antibiotics in critically ill patients","volume":"15","author":"Denny","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155254_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/38.1.5","article-title":"Is continuous infusion of beta-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations","volume":"38","author":"Mouton","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155254_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14787210.2023.2184347","article-title":"Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy","volume":"21","author":"Roberts","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155254_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2024.9779","article-title":"Continuous vs intermittent beta-lactam antibiotic infusions in critically ill patients with Sepsis: the BLING III randomized clinical trial","volume":"332","author":"Dulhunty","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155254_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2023.10598","article-title":"Continuous vs intermittent Meropenem Administration in Critically ill Patients with Sepsis: the MERCY randomized clinical trial","volume":"330","author":"Monti","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155254_bb0055","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of beta-lactam antibiotics in adults with Sepsis or septic shock: a systematic review and Meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155254_bb0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-024-05139-z","article-title":"Do prolonged infusions of beta-lactam antibiotics improve outcomes in critically ill patients with sepsis? It is time to say yes","volume":"28","author":"Li","year":"2024","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155254_bb0065","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","article-title":"Beta-lactam infusion in severe Sepsis (BLISS): a prospective, two-Centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis","volume":"42","author":"Abdul-Aziz","year":"2016","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.jcrc.2025.155254_bb0070","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.201505-0857OC","article-title":"A multicenter randomized trial of continuous versus intermittent beta-lactam infusion in severe Sepsis","volume":"192","author":"Dulhunty","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155254_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107309","article-title":"Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams","volume":"64","author":"Rolain","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155254_bb0080","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.21037\/tp-20-310","article-title":"Challenges and solutions in translating sepsis guidelines into practice in resource-limited settings","volume":"10","author":"Ranjit","year":"2021","journal-title":"Transl Pediatr"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155254_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-018-1073-z","article-title":"Measuring and mapping the global burden of antimicrobial resistance","volume":"16","author":"Hay","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155254_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13756-020-00871-x","article-title":"Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review","volume":"10","author":"Saharman","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155254_bb0095","article-title":"Optimizing Betalactam clinical response by using a continuous infusion: a comprehensive review","volume":"12","author":"Diamantis","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155254_bb0100","doi-asserted-by":"crossref","first-page":"e3265","DOI":"10.1111\/hsc.13898","article-title":"Identifying barriers and facilitators of translating research evidence into clinical practice: a systematic review of reviews","volume":"30","author":"Abu-Odah","year":"2022","journal-title":"Health Soc Care Community"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155254_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/cc1446","article-title":"Translating research evidence into clinical practice: new challenges for critical care","volume":"6","author":"Kalassian","year":"2002","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155254_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-7-50","article-title":"Knowledge translation of research findings","volume":"7","author":"Grimshaw","year":"2012","journal-title":"Implement Sci"},{"issue":"10480","key":"10.1016\/j.jcrc.2025.155254_bb0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(24)02846-0","article-title":"African critical illness outcomes study I. The African critical illness outcomes study (ACIOS): a point prevalence study of critical illness in 22 nations in Africa","volume":"405","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155254_bb0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11739-022-03179-3","article-title":"Sepsis in Brazilian emergency departments: a prospective multicenter observational study","volume":"18","author":"Machado","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155254_bb0125","doi-asserted-by":"crossref","DOI":"10.9745\/GHSP-D-21-00757","article-title":"Diversifying implementation science: a global perspective","volume":"10","author":"Bartels","year":"2022","journal-title":"Glob Health Sci Pract"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155254_bb0130","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00134-024-07650-x","article-title":"Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations","volume":"50","author":"Barton","year":"2024","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155254_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ajhp\/54.4.412","article-title":"Stability of meropenem in intravenous solutions","volume":"54","author":"Patel","year":"1997","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155254_bb0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0018578718779009","article-title":"Stability of Meropenem after reconstitution for administration by prolonged infusion","volume":"54","author":"Fawaz","year":"2019","journal-title":"Hosp Pharm"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155254_bb0145","first-page":"283","article-title":"Stability of generic brands of meropenem reconstituted in isotonic saline","volume":"81","author":"Carlier","year":"2015","journal-title":"Minerva Anestesiol"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155254_bb0150","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.ajic.2021.04.077","article-title":"International nosocomial infection control consortium (INICC) report, data summary of 45 countries for 2013-2018, adult and pediatric units, device-associated module","volume":"49","author":"Rosenthal","year":"2021","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155254_bb0155","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajic.2023.12.010","article-title":"Decreasing central line-associated bloodstream infections rates in intensive care units in 30 low- and middle-income countries: an INICC approach","volume":"52","author":"Rosenthal","year":"2024","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jcrc.2025.155254_bb0160","series-title":"ISMP summit on the use of smart infusion pumps: guidelines for safe implementation and use","author":"Gaston","year":"2010"},{"key":"10.1016\/j.jcrc.2025.155254_bb0165","series-title":"Making healthcare Safer III: a critical analysis of existing and emerging patient safety practices","author":"Hall","year":"2020"},{"issue":"11","key":"10.1016\/j.jcrc.2025.155254_bb0170","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00134-024-07662-7","article-title":"Environmental sustainability in intensive care: the path forward. An ESICM green paper","volume":"50","author":"De Waele","year":"2024","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155254_bb0175","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00134-024-07763-3","article-title":"Include environmental sustainability in clinical trial design and implementation strategies: the BLING-III trial as an illustrative example","volume":"51","author":"Klasen","year":"2025","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155254_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1060028019865873","article-title":"Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update","volume":"54","author":"Hoff","year":"2020","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155254_bb0185","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/CCM.0000000000000317","article-title":"The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*","volume":"42","author":"Jamal","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155254_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcrc.2021.09.011","article-title":"Trough concentrations of meropenem and piperacillin during slow extended dialysis in critically ill patients with intermittent and continuous infusion: a prospective observational study","volume":"67","author":"Liebchen","year":"2022","journal-title":"J Crit Care"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155254_bb0195","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/jac\/dkad223","article-title":"The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting","volume":"78","author":"Pai Mangalore","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155254_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106868","article-title":"Factors associated with meropenem pharmacokinetic\/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion","volume":"62","author":"Tournayre","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155254_bb0205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","article-title":"Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience","volume":"47","author":"Richter","year":"2019","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155254_bb0210","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijantimicag.2016.12.022","article-title":"Association between augmented renal clearance and clinical outcomes in patients receiving \u03b2-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial","volume":"49","author":"Udy","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155254_bb0215","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1007\/s00134-022-06921-9","article-title":"Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial","volume":"48","author":"Ewoldt","year":"2022","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155254_bb0220","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00134-022-06969-7","article-title":"Advancing precision-based antimicrobial dosing in critically ill patients","volume":"49","author":"Cotta","year":"2023","journal-title":"Intensive Care Med"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:44:12Z","timestamp":1787139852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944125002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"alternative-id":["S0883944125002412"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155254","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous infusion of Beta-Lactams in the critically ill: Considerations for global implementation","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155254"}}